Ensysce Biosciences (ENSC) Stock Forecast & Price Target

$0.43

+0.01 (+2.39%)

(As of 07/26/2024 ET)

Ensysce Biosciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 1 Analyst Ratings

Based on 1 Wall Street analysts who have issued ratings for Ensysce Biosciences in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for ENSC.

Consensus Price Target

$7.00
1,535.90% Upside

High Forecast	$7.00
Average Forecast	$7.00
Low Forecast	$7.00

According to the 1 analysts' twelve-month price targets for Ensysce Biosciences, the average price target is $7.00. The highest price target for ENSC is $7.00, while the lowest price target for ENSC is $7.00. The average price target represents a forecasted upside of 1,535.90% from the current price of $0.43.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	2 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$7.00	$7.00	$7.00	$15.00
Forecasted Upside	1,535.90% Upside	360.53% Upside	360.53% Upside	-20.72% Downside

Get Ensysce Biosciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ENSC and its competitors with MarketBeat's FREE daily newsletter.

Ad DTI

How to build the ultimate dividend portfolio

There’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.

Click here and I’ll show you how to build the ultimate dividend portfolio.

ENSC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ENSC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Ensysce Biosciences Stock vs. The Competition

Type	Ensysce Biosciences	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.72	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	1,535.90% Upside	3,121.53% Upside	9.09% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
9/25/2023	HC Wainwright 3 of 5 stars	B. Pachaiyappan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$9.00 ➝ $7.00	+360.52%
4/12/2023	Lake Street Capital 3 of 5 stars		Lower Target		$96.00 ➝ $15.00	+298.94%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 07:14 AM ET.

ENSC Forecast - Frequently Asked Questions

What is Ensysce Biosciences' forecast for 2024?: According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Ensysce Biosciences is $7.00, with a high forecast of $7.00 and a low forecast of $7.00.
Should I buy or sell Ensysce Biosciences stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ensysce Biosciences in the last year. There is currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ENSC shares.
Does Ensysce Biosciences's stock price have much upside?: According to analysts, Ensysce Biosciences's stock has a predicted upside of 360.53% based on their 12-month stock forecasts.
Do Wall Street analysts like Ensysce Biosciences more than its competitors?: Analysts like Ensysce Biosciences more than other "medical" companies. The consensus rating for Ensysce Biosciences is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ENSC compares to other companies.